Scientists have identified gene mutations that reduce levels of fatty triglycerides in some people and cut their risks for a heart attack, potentially paving the way for new types of drugs.
The history of oncology is rife with reports of patients with advanced cancer who staged miraculous recoveries.
When stock and bond markets took a dive in late January, hedge-fund manager David Ford kept his cool.
Stanley Baker can’t remember feeling quite so free in a very long time.
A bionic pancreas designed to take over blood sugar control in people with type 1 diabetes got patients to near normal levels and prevented dangerous drops better than standard therapy in two demanding five-day trials.